MedTrace Logo

Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals

NCT02914119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30430

Last updated 2019-09-12

Study results available
· View outcomes & findings →

Summary

Aim: To explore

* the frequency of use of objective neuromuscular monitoring for assessment of depth of neuromuscular blockade in general anaesthesia
* the incidence of residual neuromuscular blockade, and
* the timing of reversal of the neuromuscular blockade at the end of anaesthesia.

We will collect data from 7 Danish anaesthesia departments, using data from the Anaesthesia Information Management System (AIMS).

Conditions

  • Neuromuscular Blockade

Interventions

DRUG

Rocuronium

DRUG

Succinylcholine

DRUG

Cisatracurium

DRUG

Mivacurium

DEVICE

Objective neuromuscular monitoring (acceleromyography)

DRUG

Sugammadex

DRUG

Neostigmine

Sponsors & Collaborators

Principal Investigators

  • Jakob L Thomsen, MD · Sponsor principal investigator

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2017-06-01
Completion
2017-06-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02914119 on ClinicalTrials.gov